Clinical trial
A Multi-center, Randomized Controlled Clinical Trial Evaluating the Effect of Fresh Amniotic Membrane in the Treatment of Diabetic Foot Ulcers: Crossover Group From Standard of Care
NCT03205436 is registered in ClinicalTrials.gov with Organogenesis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-center, Randomized Controlled Clinical Trial Evaluating the Effect of Fresh Amniotic Membrane in the Treatment of Diabetic Foot Ulcers: Crossover Group From Standard of Care
- Lead sponsor
- Organogenesis
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 1, 2017
- Completion date
- August 15, 2019
- Enrollment
- 20 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic foot ulcer